Mérieux Equity Partners

Developer of a pacing device designed to maintain cardiac rhythm. The company's implanted leadless pacemakers incorporate a self-sustaining power patented technology harvesting the heart's kinetic energy and bringing disruptive technologies to conventional leadless pacemakers, enabling patients and healthcare professionals with cost-effective alternatives that will revolutionize patients' quality of life.

Dental Monitoring SAS is a Paris-based company established in 2015 that specializes in providing a web-based orthodontic monitoring solution. This innovative platform enables patients to capture and transmit images of their tooth movements through mobile devices, facilitating remote communication with orthodontists. The technology allows orthodontists to monitor and manage treatment plans effectively without the need for frequent in-office visits. Since its inception, the company has experienced significant growth, expanding its team to over 200 professionals across Europe, the USA, Australia, Hong Kong, and Singapore. Founded by Philippe Salah, who has extensive academic credentials in bioinformatics and biophysics, Dental Monitoring is at the forefront of integrating digital solutions into orthodontic care.

Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.

AcuSurgical is a startup developing a robotic assistant for vitreo-retinal surgery.

Plantex is a manufacturer of plant extracts for nutraceutical, food, animal nutrition, and cosmetic use. Plantex combines its knowledge of plants and its skill as a producer to meet your requirements for authenticity, efficiency, and innovation.

TARA Biosystems, Inc. is a biotechnology company focused on developing organ-on-a-chip technology, specifically human cardiac tissue models, to enhance drug discovery and safety assessments. Founded in 2014 and based in the United States, the company utilizes stem cell-derived cardiac tissue that mimics adult physiological conditions, enabling precise measurement of cardiac functionality. This innovative platform aims to facilitate the faster and safer development of new therapies by providing predictive in vitro models that can assess the effects of drug compounds on heart function without the need for human testing. Through its advanced technology, TARA Biosystems seeks to improve the health of patients by enabling more reliable assessments of cardiac drug efficacy and safety.

Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.

Addmedica S.A.S. is a French company that specializes in manufacturing and distributing medical devices and personalized medical products aimed at treating patients with rare and serious medical conditions. Founded in 2005 and headquartered in Paris, Addmedica focuses on therapeutic equipment, wound healing devices, and hematology products. The company addresses unmet medical needs in niche markets, particularly in areas such as lung transplantation, deep burn care, and sickle cell disease. By developing innovative solutions that can be used alongside or as alternatives to traditional medications, Addmedica provides significant value to healthcare professionals and patients alike. Its dedicated European organization allows the company to effectively target and procure medical products globally, ensuring that they meet the specific needs of those requiring specialized care.

Mabtech AB is a biotechnology company based in Stockholm, Sweden, founded in 1986. The company specializes in the development, manufacturing, and marketing of monoclonal antibodies and various assay kits, including those for enzyme-linked immunoassays such as ELISA, ELISpot, and FluoroSpot. Mabtech's product range includes monoclonal antibodies for a variety of applications, as well as specialized kits for detecting cytokines and other immunological molecules in biological samples from multiple species, including humans and various animals. The company aims to support the global scientific community by providing efficient tools that streamline the biomedical research process. Mabtech operates internationally, with locations in the United States, Australia, Germany, and France, and offers its products online. It is a subsidiary of Mabtech Group AB.